Home Online Features Taiwan's ACRO Biomedical Gains Regulatory Approval for Its Collagen Ophthalmic Matrix, Offering New Hope for Corneal Transplant Patients
Taiwan’s ACRO Biomedical Gains Regulatory Approval for Its Collagen Ophthalmic Matrix, Offering New Hope for Corneal Transplant Patients
Hand-out
Press Releases
April 13, 2025

Taiwan’s ACRO Biomedical Gains Regulatory Approval for Its Collagen Ophthalmic Matrix, Offering New Hope for Corneal Transplant Patients

By ACRO Biomedical Co., Ltd.

KAOHSIUNG, April 14, 2025 /PRNewswire/ -- Taiwan – ACRO Biomedical Co., Ltd. (TWSE: 6748) announced today that its ABCcolla® Collagen Ophthalmic Matrix has received regulatory approval from Taiwan's Ministry of

bradford

The Bradford Era

email
Local & Social